Notch signaling has been reported to positively control CXCR4/SDF-1 expression and functions in myeloma cell lines, and forced CXCR4 activation partially rescues tumor cells from the effects of Notch inhibition [62]. The gene discussed is CXCL12; the disease is plasma cell myeloma.